Axo Longevity

London, United Kingdom

seed$5M raisedFreshly fundedLongevity & WellnessDigital HealthBiotech

◆ Total Raised

$5M

◆ Stage

seed

◆ Location

London, United Kingdom

◆ Founded

2025

◆ Team size

11-50

◆ Links

Website ↗LinkedIn ↗

◆ About Axo Longevity

A global preventive health membership platform offering comprehensive biomarker testing, personalized health blueprints and ongoing tracking across Europe and Latin America.

◆ What sets it apart

It combines comprehensive 100+ biomarker testing with personalized, ongoing health tracking and AI-driven insights in a consumer membership model.

◆ Sectors

Longevity & WellnessDigital HealthBiotech

◆ Business

Modelmembership

CustomerHealth-conscious consumers, high performers, and people seeking preventive health and longevity optimization

◆ Notable

Operating across the United Kingdom, Ireland, Spain, Germany, the Netherlands, and Peru
Raised an oversubscribed $5M seed round

◆ Funding rounds

seed$5M

15 Sept 2026

Led by MS&AD Ventures

With Izou Partners, LifeX Ventures, Everywhere Ventures, UNQ, 51 Ventures, Cistern Capital, NIAN Sports & Entertainment

Source ↗

◆ Explore the market

Longevity & Wellness Digital Health Biotech Seed United Kingdom Ireland Spain

◆ FAQ

What does Axo Longevity do?

A global preventive health membership platform offering comprehensive biomarker testing, personalized health blueprints and ongoing tracking across Europe and Latin America.

Where is Axo Longevity based?

Axo Longevity is based in London, United Kingdom, founded in 2025.

How much has Axo Longevity raised?

Axo Longevity has raised $5M in tracked funding and is currently at the seed stage.